SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Greenbrook TMS, Inc. (OTC – GBNHF)
BALA CYNWYD – August 12, 2024 /Globe Newswire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Greenbrook TMS, Inc. (“Greenbrook TMS” or the “Company”) (OTC – GBNHF) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Neuronetics, Inc. (“Neuronetics”) (Nasdaq – STIM) in an all-stock transaction. Under the terms of the agreement, each Greenbrook share is expected to be exchanged for 0.01149 shares of Neuronetics common stock at the closing of the transaction. Following the closing of the transaction, Neuronetics shareholders will own approximately 57% of the combined company, and Greenbrook shareholders will own approximately 43% of the combined company, respectively, on a fully diluted basis.
The investigation concerns whether the Greenbrook TMS Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Neuronetics is paying fair value to shareholders of the Company.
If you own shares of Greenbrook TMS stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman by email at clients@brodsky-smith.com, or call toll free 855-576-4847.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.